Biotechnology
A cancer drug that cannot be manufactured in a factory, because it is made out of the patient
30 Aug 2026 · 9 min read
CAR-T therapy takes a patient's own immune cells, gives them a receptor that does not exist in nature, and puts them back. It has cured people whose leukaemia had run out of options — and its cost, its side effects and its failure against solid tumours all trace to the same design.
Read more →
